.png){kind=icon}
Return
Batch nonlinear continuous-time trajectory estimation as exactly sparse Gaussian process regression
.png){kind=icon}
PRE
AI
DOI：10.1007/s10514-015-9455-y.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
In this paper, we revisit batch state estimation through the lens of Gaussian process (GP) regression. We consider continuous-discrete estimation problems wherein a trajectory is viewed as a one-dimensional GP, with time as the independent variable. Our continuous-time prior can be defined by any nonlinear, time-varying stochastic differential equation driven by white noise; this allows the possibility of smoothing our trajectory estimates using a variety of vehicle dynamics models (e.g. 'constant-velocity'). We show that this class of prior results in an inverse kernel matrix (i.e., covariance matrix between all pairs of measurement times) that is exactly sparse (block-tridiagonal) and that this can be exploited to carry out GP regression (and interpolation) very efficiently. When the prior is based on a linear, time-varying stochastic differential equation and the measurement model is also linear, this GP approach is equivalent to classical, discrete-time smoothing (at the measurement times); when a nonlinearity is present, we iterate over the whole trajectory to maximize accuracy. We test the approach experimentally on a simultaneous trajectory estimation and mapping problem using a mobile robot dataset.
Keywords:
State estimation
Localization
Continuous time
Gaussian process regression
Journal
IF:
4.3
Papers:
1.7K
Citations:
5.0K
Organization
Cited Papers
Applying LiDAR to Quantify the Plant Area Index Along a Successional Gradient in a Tropical Forest of Thailand.png)
Forests
OAAI
ForestsIF0
OAAIShareSaveSuppression of respiratory growth defect of mitochondrial phosphatidylserine decarboxylase deficient mutant by overproduction of Sfh1, a Sec14 homolog, in yeastPLOS ONEOAAI
PLOS ONEIF0
OAAIShareSaveCumulative Efficacy and Safety of 5-Year Deferasirox (Exjade®) Treatment in Pediatric Patients with Thalassemia Major: A Phase II Multicenter Prospective TrialBlood
BloodIF0
PREAI
ShareSaveShareSaveShareSaveShareSaveShareSave
View more